Partially hydrogenated soybean oil reduces postprandial t-PA activity compared with palm oil

Atherosclerosis

Volumn 155, Issue 2, 2001, Pages 467-476

  Müller, Hanne ^a   Seljeflot, Ingebjorg ^c   Solvoll, Kari ^b   Pedersen, Jan I ^a,b  

^a OSLO METROPOLITAN UNIVERSITY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Coagulation; Diet; Fibrinolysis; Hydrogenation; Palmitic acid; Trans Fatty acids

Indexed keywords

BLOOD CLOTTING FACTOR 7; CHOLESTEROL; FATTY ACID; FIBRINOGEN; PALM OIL; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYUNSATURATED FATTY ACID; SOYBEAN OIL; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FEMALE; FIBRINOGENOLYSIS; HEMOLYSIS; HOMEOSTASIS; HUMAN; HYDROGENATION; METABOLIC REGULATION; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; SOYBEAN;

EID: 0035092236     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00591-8     Document Type: Article

References (53)

1. Dietary regulation of fibrinolytic factors
2. Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on hemostatic variables in men
3. Association between dietary fat intake and plasma factor VII coagulant activity: A predictor of cardiovascular mortality
4. Dietary changes in fasting levels of factor VII coagulant activity (FVII:C) are accompanied by changes in factor VII protein and other vitamin K-dependent proteins
5. Effects of dietary fat quality and quantity on postprandial activation of blood coagulation factor VII
6. Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis
7. Coagulation and fibrinolysis factors in healthy subjects consuming high stearic or trans fatty acids diets
8. Lipoprotein metabolism and trans fatty acids
9. Diurnal variation of the fibrinolytic system
10. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1)
11. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1)
12. Fluctuations of euglobulin lysis time, tissue plasminogen activator, and free and total plasminogen activator inhibitor levels in plasma in daytime
13. Dietary effects on circadian fluctuation in human blood coagulation factor VII and fibrinolysis
14. Replacement of partially hydrogenated soybean oil by palm oil in margarine without unfavorable effects on serum lipoproteins
15. Accuracy of a quantitative food frequency questionnaire applied in elderly Norwegian women
16. Energy and Protein Requirements
17. Study of the food consumption by the Duplicate Portion Technique in a small sample of the Dalby population
18. Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal t-PA activity
19. Gerinnungsphysiologische schnellmetode zur bestimmung des fibrinogens
20. Plasma lipoprotein lipid and Lp(a) changes with substitution of elaidic acid for oleic acid in the diet
21. Effect of dietary cis and trans fatty acids on serum lipoprotein(a) levels in humans
22. Stearic acid, trans fatty acids, and dairy fat: Effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein (a), and lipid transfer proteins in healthy subjects
23. Lipoprotein (a) fibrin binding, and plasminogen activation
24. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis
25. Endogenous tissue-type plasminogen activator and risk of myocardial infarction
26. Insulin action and fibrinolysis influenced by vitamin E in obese type 2 diabetes mellitus
27. Low-fat high-fiber diet favorably affects several independent risk markers of ischemic heart disease: Observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes
28. Plasminogen activator and plasminogen activator inhibitor activities in a reference population
29. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females
30. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations
31. The diurnal increase in euglobulin fibrinolytic activity in women using oral contraceptives and in normal women, and the generation of intrinsic fibrinolytic activity
32. Haemostatic factors and risk of myocardial infarction or sudden death in patients with angina pectoris
33. Haemostatic factors and atherogenesis
34. Dietary factors in thrombosis and hemostasis: Summary and conclusions
35. Association of fibrinolytic parameters with early atherosclerosis
36. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
37. An epidemiological assessment of thrombotic risk factors for cardiovascular disease
38. Tissue-type plasminogen activator and plasminogen activator inhibitor activities as predictors of adverse events in unstable angina
39. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris
40. Tissue-type plasminogen activator and type-1 plasminogen activator inhibitor in patients with coronary artery disease - Relations to clinical variables and cardiovascular risk factors
41. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
42. Plasminogen activator expression in human atherosclerotic lesions
43. Inhibitors of fibrinolysis are elevated in atherosclerotic plaque
44. Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease
45. Haemostatic function and ishaemic heart disease: Principal results of the Northwick Park Hearth Study (NPHS)
46. Trans-fatty acid patterns in patients with angiographically documented coronary artery disease
47. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men
48. Trans-fatty acids intake and risk of myocardial infarction
49. Dietary fat intake and the risk of coronary heart disease in women
50. Adipose tissue isometric trans fatty acids and risk of myocardial infarction in nine countries: The EURAMIC study
51. Trans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death
52. Effect of palm oil, margarine, butter and sunflower oil on the serum lipids and lipoproteins of normocholesterolemic middle-aged men
53. Plasminogen activator inhibitor-1, tissue-type plasminogen activator and fibrinogen. Effect of dieting with or without exercise in overweight postmenopausal women